Patents by Inventor Shunji Nagahara

Shunji Nagahara has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8742091
    Abstract: Means for transferring efficiently a desired nucleic acid into a cell is provided. The present invention comprises using a complex comprising a collagen or a collagen derivative, and a desired nucleic acid.
    Type: Grant
    Filed: June 20, 2002
    Date of Patent: June 3, 2014
    Assignees: Dainippon Sumitomo Pharma Co., Ltd., Koken Co., Ltd., National Cancer Center
    Inventors: Masaaki Terada, Takahiro Ochiya, Yu Aso, Kimi Honma, Akihiko Sano, Shunji Nagahara
  • Publication number: 20110217366
    Abstract: The present invention provides an immunopotentiating composition which comprises an antigen or antigen-inducing substance, and a carrier comprising a biocompatible material for effectively increasing an immune response derived from an antigen. The present invention further provides a method of producing an antibody by administering said immunopotentiating composition to a mammal or bird, thereby modulating the immune response in said mammal or bird and recovering the antibody produced.
    Type: Application
    Filed: May 17, 2011
    Publication date: September 8, 2011
    Applicants: Dainippon Sumitomo Pharma Co., Ltd., The University of Melbourne, KONEN CO., LTD.
    Inventors: Keiji FUJIOKA, Akihiko Sano, Shunji Nagahara, Malcolm Roy Brandon, Andrew Donald Nash, Shari Lofthouse
  • Publication number: 20110028535
    Abstract: Preparations for transferring efficiently oligonucleotides necessary in antisense therapy or the like into animal cells so as to be useful in treatment for various diseases, which comprises a collagen as an essential component are provided.
    Type: Application
    Filed: October 13, 2010
    Publication date: February 3, 2011
    Applicants: Koken Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., National Cancer Center
    Inventors: Shunichiro KUBOTA, Masaaki Terada, Takahiro Ochiya, Hiroshi Itoh, Masayasu Furuse, Akihiko Sano, Shunji Nagahara
  • Publication number: 20100081202
    Abstract: Means for transferring efficiently a desired nucleic acid into a cell is provided. The present invention comprises using a complex comprising a collagen or a collagen derivative, and a desired nucleic acid.
    Type: Application
    Filed: September 4, 2009
    Publication date: April 1, 2010
    Inventors: Masaaki Terada, Takahiro Ochiya, Yu Aso, Kimi Honma, Akihiko Sano, Shunji Nagahara
  • Publication number: 20090258933
    Abstract: Preparations for transferring efficiently oligonucleotides necessary in antisense therapy or the like into animal cells so as to be useful in treatment for various diseases, which comprises a collagen as an essential component are provided.
    Type: Application
    Filed: June 17, 2009
    Publication date: October 15, 2009
    Applicant: Dainippon Pharmaceutical Co., Ltd.
    Inventors: Shunichiro KUBOTA, Masaaki Terada, Takahiro Ochiya, Hiroshi Itoh, Masayasu Furuse, Akihiko Sano, Shunji Nagahara
  • Publication number: 20060258602
    Abstract: It is intended to provide a preparation whereby an oligonucleotide is efficiently transferred into a cell and the localization thereof in nucleus is promoted, a preparation for facilitating the conversion of the base sequence of a target genomic gene, and a preparation for gene therapy. Namely, a preparation for facilitating site-specific gene conversion which comprises at least a collagen and an oligonucleotide for gene conversion; a preparation for site-specific gene therapy which comprises at least a collagen and an oligonucleotide for gene conversion; a method of arbitrarily converting a specific base on a genomic gene in the nucleus of a cell which comprises bringing the above-described preparation for facilitating gene conversion into contact with the cell; and an preparation for facilitating oligonucleotide intranuclear localization which comprises at least a collagen and an oligonucleoitde.
    Type: Application
    Filed: September 19, 2003
    Publication date: November 16, 2006
    Inventors: Yukio Ando, Masaaki Nakamura, Shunji Nagahara
  • Patent number: 7052875
    Abstract: The invention is directed to the retention of the stability of formulations useful for a gene therapy during the preparation and preservation. In the invention, at least one saccharide and/or at least one non-hydrophobic amino acid and/or at least one organic acid having two or more carboxyl groups except amino acids, or a collagen or a gelatin and at least one amino acid are added to a gene formulation.
    Type: Grant
    Filed: May 19, 1999
    Date of Patent: May 30, 2006
    Assignees: Sumitomo Pharmaceutical Company, Limited, Koken Co., Ltd.
    Inventors: Masaaki Terada, Takahiro Ochiya, Akihiko Sano, Akihiko Hisada, Shunji Nagahara
  • Publication number: 20040266004
    Abstract: Means for transferring efficiently a desired nucleic acid into a cell is provided.
    Type: Application
    Filed: December 19, 2003
    Publication date: December 30, 2004
    Inventors: Masaaki Terada, Takahiro Ochiya, Yu Aso, Kimi Honma, Akihiko Sano, Shunji Nagahara
  • Publication number: 20040052840
    Abstract: Preparations for transferring efficiently oligonucleotides necessary in antisense therapy or the like into animal cells so as to be useful in treatment for various diseases, which comprises a collagen as an essential component are provided.
    Type: Application
    Filed: June 23, 2003
    Publication date: March 18, 2004
    Inventors: Shunichiro Kubota, Masaaki Terada, Takahiro Ochiya, Hiroshi Itoh, Masayasu Furuse, Akihiko Sano, Shunji Nagahara